| Document |
Document Title |
|
JPH0564942B2 |
The invention relates to the new N-[2-/4-fluorophenyl/-1-methyl]-ethyl-N-methyl-N-propynyl amine of the Formula I (I) and isomers and salts thereof. The compound of the formula I is useful as a selective MAO inhibitor.
|
|
JPH0560994B2 |
|
|
JPH0559921B2 |
An energy polymerizable composition and process therefore, comprising a cationically polymerizable material and a catalytically effective amount of an ionic salt of an organometallic complex cation as polymerization initiator, said ionic...
|
|
JPH05221958A |
PURPOSE: To provide a new compd. as a complexing agent for nuclides which can be used for nuclear medicine. CONSTITUTION: This compd. is expressed by formula I, wherein T is S, O; R1 is O or S bonded with R2; R1 to R4 are H, -(CH2)a-CH3,...
|
|
JPH05505831A |
The present invention relates to a process for preparing platinum group metal and rhenium salts of organic carboxylic acids and products obtained using the disclosed process. The process comprises reacting an alkali or alkaline earth met...
|
|
JPH05505624A |
The present invention relates to novel preorganized hexadentate ligands suitable for complexing with a radionuclide to form imaging agents for diagnostic purposes. The ligands have the formula: (I) wherein a) R2 is hydrogen and R3 is met...
|
|
JPH05186487A |
PURPOSE: To obtain a high purity dinuclear manganese (III) complex in a short reaction time and a high yield by allowing a manganese (III) salt to react with a ligand L-contg. compd. in a nonaq. solvent. CONSTITUTION: A manganese (III) s...
|
|
JPH05504777A |
The present invention relates particularly to novel preorganized hexadentate ligands that are suitable for complexing with a radionuclide, and are useful as general imaging agents for diagnostic purposes.
|
|
JPH0544931B2 |
Complexes of technetium-99m with alkylene amine oximes having 2 or 3 carbon atoms inthe alkylene group have a core with a zero net charge, contain an 0-H-O ring closure bond and are sufficiently stable for parenteral administration. Such...
|
|
JPH05148283A |
PURPOSE: To obtain the subject novel chelate forming compd. which is useful as an in vivo diagnostic agent and a medicament for tumor treatment and has a reducing property and tissue specificity. CONSTITUTION: A compd. of formula I [X is...
|
|
JPH05503033A |
The invention pertains to rhenium (VII) compounds which are catalysts for metathesis of ordinary olefins (hydrocarbons) and functionalized olefins in a homogeneous phase and to methods of synthesizing these compounds. The rhenium compoun...
|
|
JPH0529357B2 |
|
|
JPH0482159B2 |
|
|
JPH04507401A |
(57) [Abstract] Since this gazette is application data in front of an electronic application, the data of an abstract is not recorded.
|
|
JPH0480013B2 |
The separation of organometallic compounds and/or metal carbonyls from their solutions in organic media is effected according to the invention with the aid of semipermeable membranes of an aromatic polyamide.
|
|
JPH04334394A |
PURPOSE: To obtain the title treating composition useful for bleaching after color development of sensitized material of silver halide color photography, capable of carrying out treatment having excellent desilvering properties with a li...
|
|
JPH0472818B2 |
New intermediates and processes for preparing 6-halo-7,8-dihydroxy-1-(p-hydroxyphenyl)-2,3,4,5-tetrahydro-
1H-3-benza zepines involve the reaction of a p-methoxyphenylglyoxal, lower alkyl hemimercaptal with a 2-chloro-3,4-dimethoxyphenet...
|
|
JPH04305589A |
PURPOSE: To provide novel compds. which are useful as peroxide decomposing agents. CONSTITUTION: The compd. of formula I (M is Mg, Ca, Sr, Ba or their mixture; R is H, hydrocarbyl; L is the ligand of formula II). This compd. is obtd. by ...
|
|
JPH04305590A |
PURPOSE: To provide novel compds. having a magnetic rate useful for use in magnetic temp. measurement and magnetic fluid. CONSTITUTION: The compd. of formula I (x is 0 to 32; L is a ligand having formula II). This compd. is obtd. by diss...
|
|
JPH04266878A |
PURPOSE: To industrially and advantageously obtain the subject compound by reacting a specific double bond-containing compound with an oxygen-containing gas in the presence of a manganese compound and an aldehyde compound. CONSTITUTION: ...
|
|
JPH04253968A |
PURPOSE: To provide binuclear metal macrocyclic and macrobicyclic complexes for oxygen separation and transport and a method for extracting oxygen from a gaseous mixture contg. the oxygen. CONSTITUTION: The binuclear metallic complex whi...
|
|
JPH04212099A |
PURPOSE: To obtain diagnostic video agent or radiation therapy agent by using specific boric acid adduct. CONSTITUTION: The boric acid adduct of technetium-99m dioxime or rhenium dioxime complex is represented by a formula MX (Y3) Z, whe...
|
|
JPH0445107B2 |
|
|
JPH0437802B2 |
PURPOSE:An antibacterial agent consisting of an L-ascorbic acid derivative, and, if necessary, a salt of a divalent transition metal. CONSTITUTION:An ascorbic acid derivative shown by the formula I (X1-3 is H, 2-21C acyl, polyfluoroacyl,...
|
|
JPH0437068B2 |
A method of making 1:1 complex salts of alpha amino acids and a metal ion which is either zinc or manganese, the method comprising reacting a water soluble zinc salt or manganese salt with an alpha amino acid in the presence of catalytic...
|
|
JPH04502754A |
A ligated technetium (III/II) complex is useful as a brain perfusion imaging agent. The complex has a technetium (III/II) center surrounded by six ligating moieties. The complex preferably has a reduction potential Tc(III) to Tc(II) whic...
|
|
JPH0424356B2 |
New technetium [99m] (1) complexes can be used in imaging compositions for example in myocardial imaging. The complexes have one of the following formulae: <99m>Tc (I) [P(R<1>, R<2>, R<3>)]6<+>A<-> 1 wherein R<1>, R<2> and R<3> are indep...
|
|
JPH0421671B2 |
Novel homocysteine thiolactone bifunctional chelating agents useful for chelating radionuclides to produce a radiodiagnostic agent for use in in vivo imaging and a method for producing this chelating agent.
|
|
JPH0420901B2 |
Pharmaceutically useful optically active alpha -arylalkanoic acids of the formula where Ar is aryl and R1 is alkyl or cycloalkyl or esters, ortho esters, or amides thereof are stereoselectively prepared by contacting a reagent of the for...
|
|
JPH04501232A |
PCT No. PCT/FR90/00601 Sec. 371 Date Apr. 3, 1991 Sec. 102(e) Date Apr. 3, 1991 PCT Filed Aug. 7, 1990 PCT Pub. No. WO91/01806 PCT Pub. Date Feb. 21, 1991.There is disclosed a catalyst for the liquid phase oxidation of functional groups ...
|
|
JPH0411553B2 |
Boronic acid adducts of technetium-99m dioxime complexes are useful for imaging the myocardium, hepatobiliary system, brain and blood pool in humans and other mammalian species.
|
|
JPH04500376A |
Chelating compounds of specified structure are useful for radiolabeling targeting proteins such as antibodies. The radiolabeled antibodies, or catabolites thereof, demonstrate improved biodistribution properties, including reduced locali...
|
|
JPH04500072A |
Complexes useful as radiopharmaceutical imaging agents comprise technetium bonded to a ligand which generally can be described by the formula: wherein Z is N, C, B or P; the three Y groups can be the same or different, each characterized...
|
|
JPH0372636B2 |
Bis(triarylboraneisocyano-N)-tetrakis-(alkylnitrile) and bis(triarylboraneisocyano-N)-bis-(alkyldinitrile) metal compounds.
|
|
JPH03504974A |
A method is provided utilizing contrast agents which provide increased diagnostic information in the magnetic resonance image of the hepatobiliary system and alimentary tract, especially the small intestine. Novel contrast agents which a...
|
|
JPH03504976A |
The present invention provides conjugates formed from calcified tissues targeting agents and radiolabeled compounds. One such conjugate comprises a chelate and a targeting agent that is capable of associating with calcified tissue, where...
|
|
JPH03504725A |
PCT No. PCT/FR89/00273 Sec. 371 Date Nov. 28, 1990 Sec. 102(e) Date Nov. 28, 1990 PCT Filed Jun. 2, 1989 PCT Pub. No. WO89/12049 PCT Pub. Date Dec. 14, 1989.Metalloporphyrin derivatives of the formula I in which A and B each represents: ...
|
|
JPH0364504B2 |
Compounds suitable for NMR imaging having the formula:whereina is 2 or 3;b is an integer from 0 to 4;Me(a+) is Fe(2+), Fe(3+), Gd(3+), or Mn(2+);E(b+) is an ion of an alkali metal, alkaline earth metal, alkyl ammonium, alkanol ammonium, ...
|
|
JPH03504134A |
Polynitrogenous derivatives comprising four or five coordinating functions capable of bonding with a metal atom, especially with cobalt. The invention concerns, more particularly, the use of metal complexes comprising said derivatives fo...
|
|
JPH03197454A |
NEW MATERIAL:Propanebis(dithio)oxamide expressed by formula I and same or different metals-coordinated high polymer complex expressed by formula II [M1 and M2 are bivalent or trivalent transition metal; (l) is 0 or 1-5]. USE: The compoun...
|
|
JPH0354652B2 |
Pharmaceutically useful optically active alpha -arylalkanoic acids of the formula where Ar is aryl and R1 is alkyl or cycloalkyl or esters, ortho esters, or amides thereof are stereoselectively prepared by contacting a reagent of the for...
|
|
JPH03188048A |
NEW MATERIAL: Compounds of formula I [R1, R2 and R5 are each H, alkyl; R3 and R4 are each H, alkyl, aminoalkyl, carboxymethyl, alkoxycarbonylbenzyl, etc.; R6 is alkylene; R7 and R8 are each H, alkyl; B and B' are each phenyl substituted ...
|
|
JPH0352475B2 |
Polymeric complex compounds of molybdenum, tungsten, manganese, rhenium and of the metals of the sub-groups VIII and I of the Periodic Table of Elements, which complex compounds have a silica-type structure are disclosed. At least one am...
|
|
JPH03178969A |
PURPOSE: To stabilize 3-isothiazolone compounds contained in objects to be protected against algae, bacterial and fungal growth, by incorporating a specified salt of Cu, Zn, Mn or Fe. CONSTITUTION: A metal salt comprising a cation (e.g. ...
|
|
JPH0349915B2 |
A method of. imaging organs with 99mTc radiopharmaceuticals, especially of hepatobiliary imaging and negative myocardial infarct imaging in a mammal, which comprises administering to the mammal a hepatobiliary or myocardial imaging amoun...
|
|
JPH03148289A |
NEW MATERIAL: A compound of formula I [X is an anion such as F, Cl, etc.; Y is an imine-oxime group of formula II (R1 and R2 are each H, alkyl, etc.); Z is a vicinal dioxime group of formula III; BR3 is a boronic acid derivative; R3 is a...
|
|
JPH0339515B2 |
|
|
JPH0338889B2 |
|
|
JPH0339045B2 |
1. The use of at least one physiologically tolerable paramagnetic complex salt made from aminopolycarboxylic acids having the formulae I to IV see diagramm : EP0169299,P6,F1 N-hydroxyethyl-N,N',N'-ethylenediaminetriacetic acid (HEDTA), s...
|
|
JPH03135989A |
NEW MATERIAL: A compound of formula I {X is an anion; Y is an adjacent dioxime of formula II [R1 and R2 are each H, halogen, alkyl, aryl, amino or 5-6 membered heterocycle containing N, O or S; R1 and R2 together form -(CR8R9)n (n is 3-6...
|
